Key result
Drug-eluting stents are transitioning from cardiology to pneumonology for the management of malignant and benign endobronchial lesions using coated self-expandable designs.
Answers are grounded in this paper and cite their sources.
This paper discusses the application of drug-eluting stent technology, originally developed for cardiology, to bronchial stents in pneumonology.
Bronchial stents are usually used in the case of malignancy for endobronchial lung cancer lesions and benignancy when fibrinous tissue occurs. There are self-expandable stents with or without coati...
No takes yet. Share an insight, caveat, or question.
Zarogoulidis et al. (2024) studied this question. Drug-eluting stents are transitioning from cardiology to pneumonology for the management of malignant and benign endobronchial lesions using coated self-expandable designs.
Synapse has enriched 10 related papers. Consider them for comparative context: